Contrarian Commodities LP Amends D/A, Confirms 3(c)(1) Exemption

TL;DR

**Contrarian Commodities LP confirmed its private fund status, meaning less public scrutiny.**

AI Summary

Contrarian Commodities LP filed an amended Form D/A on March 23, 2026, updating its notice of exempt offering. The key amendment is the affirmation of its status under Investment Company Act Section 3(c)(1), which means it's exempt from registering as an investment company because it has fewer than 100 investors and does not make a public offering. This matters to potential investors because it clarifies the regulatory framework under which Contrarian Commodities LP operates, indicating it's a private fund not subject to the same public disclosure requirements as registered investment companies.

Why It Matters

This filing clarifies Contrarian Commodities LP's regulatory status as a private fund, which means it operates with less public oversight than a registered investment company. Investors should understand this distinction as it impacts transparency and investor protections.

Risk Assessment

Risk Level: medium — The 'private fund' status under Section 3(c)(1) means less regulatory oversight and public disclosure compared to registered investment companies, which can increase risk for investors due to reduced transparency.

Analyst Insight

Investors considering Contrarian Commodities LP should be aware of its private fund status and the associated implications for regulatory oversight and transparency, conducting thorough due diligence beyond public filings.

Key Numbers

• 021-399119 — File Number (Unique identifier for the offering with the SEC)
• 26781930 — Film Number (Internal SEC processing number for the filing)
• 719-540-5800 — Business Phone Number (Contact number for Contrarian Commodities LP)

Key Players & Entities

• Contrarian Commodities LP (company) — the filer of the D/A form
• 0001860153 (company) — CIK of Contrarian Commodities LP
• 842477761 (company) — EIN of Contrarian Commodities LP
• Delaware (company) — State of Incorporation for Contrarian Commodities LP
• March 23, 2026 (date) — Filing and Acceptance Date of the D/A

Forward-Looking Statements

• Contrarian Commodities LP will continue to operate as a private fund under the 3(c)(1) exemption. (Contrarian Commodities LP) — high confidence, target: 2027-03-23

FAQ

Key Financial Figures

• $1 — enues   No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,
• $1,000,000 — No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,
• $5,000,000 — Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001
• $1,000,001 — e   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000
• $5,000,001 — $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000
• $25,000,000 — $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000   $25,000,001
• $25,000,001 — $25,000,000 $5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,0
• $50,000,000 — 5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,0
• $100,000,000 — 25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $1
• $50,000,001 — 0,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $100,000,000   O

Filing Documents

• primary_doc.html (D/A)
• primary_doc.xml (D/A) — 5KB
• 0001860153-26-000002.txt ( ) — 6KB

From the Filing

Form D FORM D Notice of Exempt Offering of Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. OMB APPROVAL OMB Number: 3235-0076 Estimated Average burden hours per response: 4.0 1. Issuer's Identity CIK (Filer ID Number) Previous Name(s) None Entity Type Corporation Limited Partnership   Limited Liability Company   General Partnership   Business Trust Other   Name of Issuer   Contrarian Commodities LP Jurisdiction of Incorporation/Organization DELAWARE   Year of Incorporation/Organization Over Five Years Ago Within Last Five Years (Specify Year)   Yet to Be Formed           2. Principal Place of Business and Contact Information Name of Issuer   Contrarian Commodities LP Street Address 1 Street Address 2   c/o Contrarian Investors, L.L.C.   1962 Blake Street, Suite 200   Denver   COLORADO     80202 3. Related Persons Last Name First Name Middle Name Samelson Lincoln Street Address 1 Street Address 2   Contrarian Commodities LP     1962 Blake Street, Suite 200   Denver   COLORADO   80202   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) President and CEO of Contrarian Investors, L.L.C., the General Partner of the Issuer 4. Industry Group   Agriculture Banking & Financial Services     Commercial Banking     Insurance   Investing     Investment Banking     Pooled Investment Fund Hedge Fund Other Investment Fund Private Equity Fund Venture Capital Fund *Is the issuer registered as an investment company under the Investment Company Act of 1940? Yes  No   Other Banking & Financial Services   Business Services Energy     Coal Mining     Electric Utilities     Energy Conservation     Environmental Services     Oil & Gas     Other Energy Health Care     Biotechnology     Health Insurance     Hospitals & Physicians     Pharmaceuticals     Other Health Care                         Manufacturing Real Estate   Commercial   Construction   REITS & Finance   Residential Other Real Estate   Retailing Restaurants Technology   Computers   Telecommunications   Other Technology Travel   Airlines & Airports   Lodging & Conventions   Tourism & Travel Services   Other Travel Other        5. Issuer Size Revenue Range Aggregate Net Asset Value Range No Revenues   No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $100,000,000   Over $100,000,000   Decline to Disclose   Decline to Disclose   Not Applicable   Not Applicable   6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply) Rule 504(b)(1) (not (i), (ii) or (iii)) Rule 506(b)         Rule 504 (b)(1)(i) Rule 506(c) Rule 504 (b)(1)(ii) Securities Act Section 4(a)(5) Rule 504 (b)(1)(iii) Investment Company Act Section 3(c) Section 3(c)(1) Section 3(c)(9) Section 3(c)(2) Section 3(c)(10) Section 3(c)(3) Section 3(c)(11) Section 3(c)(4) Section 3(c)(12) Section 3(c)(5) Section 3(c)(13) Section 3(c)(6) Section 3(c)(14) Section 3(c)(7)     7. Type of Filing   New Notice Date of First Sale   2021-01-26   First Sale Yet to Occur   Amendment     8. Duration of Offering Does the Issuer intend this offering to last more than one year?   Yes   No     9. Type(s) of Securities Offered (select all that apply) Pooled Investment Fund Interests Equity Tenant-in-Common Securities Debt Mineral Property Securities Option, Warrant or Other Right to Acquire Another Security Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security Other (describe) Limited Partnership Interests     10. Business Combination Transaction Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?   Yes   No Clarification of Response (if Necessary)       11. Minimum Investment Minimum investment accepted from any outside investor $   250000 USD 12. Sales Compensation Recipient   Recipient CRD Number None     (Associated) Broker or Dealer None (Associated) Broker or Dealer CRD Number  None     Street Address 1 Street Address 2             13. Offering and Sales Amounts   Total Offering Amount $   USD Indefinite Total Amount Sold $ 5950000 USD Total Remaining to be Sold $   USD Indefinite Clarification of Response (if Necessary)      14. Investors Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, Number of such non-accredited investors who already have invested in the offering       Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in th

View Full Filing

View this D/A filing on SEC EDGAR